Illumina Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Illumina Inc. (ILMN) shares fell 2.51% to $188.29 on Tuesday, underperforming the broader market and its peers. The S&P 500 dropped 0.69%, while competitors showed mixed results: Labcorp fell 0.36%, Charles River Laboratories declined 2.60%, and Quest Diagnostics rose 0.31%. Illumina closed 9.04% below its 52-week high of $207. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Illumina Inc. (ILMN) shed 2.51% to $188.29 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
Illumina Inc. closed 9.04% short of its 52-week high of $207.00, which the company achieved on August 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Labcorp Holdings Inc. (LH) fell 0.36% to $322.18, Charles River Laboratories International Inc. (CRL) fell 2.60% to $279.19, and Quest Diagnostics Inc. (DGX) rose 0.31% to $236.25.
Trading volume (1.2 M) remained 735,787 below its 50-day average volume of 1.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-18-26 1725ET